Breaking Ground in Biotech: The Role of AI and Gene Editing, Part 2

Breaking Ground in Biotech: The Role of AI and Gene Editing, Part 2

Intelligent Medicine | The Best of High Tech Medicine and Alternative Modalities

B2July 7, 202626 min
Play

Dr. Hoffman continues his conversation with physician and molecular biologist Dr. Adrian Woolfson, co-founder of Genyro, a biotechnology company specializing in synthetic genome design and construction, and author of “On the Future of Species: Authoring Life by Means of Artificial Biological Intelligence.”

Episodes · Intelligent Medicine | The Best of High Tech Medicine and Alternative Modalities

Leyla Weighs In: Do Probiotics Hold the Key to Detoxifying Heavy Metals?

B122 min

Q&A with Leyla, Part 1: Dealing With The Heat

B233 min

Q&A with Leyla, Part 2: Is there any remedy for frequent nighttime urination?

B230 min

The Science of Immune Regulation and Resilience, Part 1

B228 min

The Science of Immune Regulation and Resilience, Part 2

B237 min

Breaking Ground in Biotech: The Role of AI and Gene Editing, Part 1

B229 min

Intelligent Medicine Radio for July 4, Part 1: Break a Sweat to Beat the Heat

B235 min

Intelligent Medicine Radio for July 4, Part 2: Causes of Excessive Sleepiness

B235 min

Leyla Weighs In: Beyond Calcium--Unraveling Nutritional Insights for Bone Strength

C121 min

Q&A with Leyla, Part 1: Carnivore Diet Controversies

B231 min

Q&A with Leyla, Part 2: Oral vs. IV Chelation

B229 min

Heart Matters: Essential Supplements for Cardiovascular Protection, Part 1

B233 min
Breaking Ground in Biotech: The Role of AI and Gene Editing, Part 2 – Intelligent Medicine | The Best of High Tech Medicine and Alternative Modalities | FlexiLingo | FlexiLingo